3 results
The primary objectives are:* to determine the effect of steady-state concentrations of TMC114 coadministered with a lowdose of ritonavir on the steady-state pharmacokinetics of ddI,* to determine the effect of steady-state concentrations of ddI on…
- To compare the pharmacokinetics (PK) of glepaglutide after a single subcutaneous (SC) administration by vial/syringe and by autoinjector.- To evaluate the safety and tolerability of glepaglutide following SC dosing in healthy subjects.
PRIMARY OBJECTIVE: to evaluate the effectiveness of the GerOnTe, ICT-based, integrated care pathway to improve patient 6-month quality of life, in Belgium and the Netherlands.SECONDARY OBJECTIVES• Evaluate the effectiveness of the GerOnTe patient-…